Autolus Therapeutics (AUTL) Cash from Operations Growth (3y) (2020 - 2025)
Autolus Therapeutics (AUTL) Cash from Operations Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - | -5.07% |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | - |
| 3 | Akari Therapeutics | 973.81 Bn | 973.81 Bn | - | - |
| 4 | BeOne Medicines | 471.51 Bn | 466.72 Bn | 1.35 Bn | 33.08% |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.70 Bn | 2.59 Bn | 16.64% |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn | -7.60% |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.88 Bn | 50.69 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 34.32% |
| 10 | Autolus Therapeutics | 392.55 Mn | 91.84 Mn | -1.04 Mn | -66.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -66.57% |
| Sep 30, 2025 | -28.63% |
| Jun 30, 2025 | -33.18% |
| Mar 31, 2025 | -29.21% |
| Dec 31, 2024 | -60.60% |
| Sep 30, 2024 | -30.22% |
| Jun 30, 2024 | -11.74% |
| Mar 31, 2024 | -2.75% |
| Dec 31, 2023 | 3.61% |
| Sep 30, 2023 | -0.95% |
| Jun 30, 2023 | -12.30% |
| Mar 31, 2023 | -20.85% |
| Jun 30, 2022 | 11.02% |
| Mar 31, 2022 | -9.72% |
| Dec 31, 2021 | -31.27% |
| Sep 30, 2021 | -3.29% |
| Jun 30, 2021 | -36.57% |
| Dec 31, 2020 | -46.62% |